Skip to main content
Figure 3 | Reproductive Biology and Endocrinology

Figure 3

From: The absorption and uptake of recombinant human follicle-stimulating hormone through vaginal subcutaneous injections - a pharmacokinetic study

Figure 3

Serum E2 concentrations after vaginal or abdominal subcutaneous injections of 425 IU recombinant human FSH in women under pituitary down-regulation with GnRH-agonist. Mean concentrations of E2 versus time points were presented. An initial higher E2 levels were noted in those of abdominal injections but a more consistent elevated E2 was found in those of vaginal injections.

Back to article page